Current Opinion in HIV & AIDS:
Current Opinion in HIV and AIDS was launched in 2006. It is one of a successful series of review journals whose unique format is designed to provide a systematic and critical assessment of the literature as presented in the many primary journals. The fields of HIV and AIDS are divided into 6 sections that are reviewed once a year. Each section is assigned a Section Editor, a leading authority in the area, who identifies the most important topics at that time. Here we are pleased to introduce the Section Editors for this issue.
Susan P. Buchbinder
Dr Susan P. Buchbinder is Director of the HIV Research Section at the San Francisco Department of Public Health, USA. She has been on the faculty at the University of California, San Francisco (UCSF) since 1988, where she serves as Associate Clinical Professor of Medicine and Epidemiology. Dr Buchbinder received her MD from UCSF in 1985 and completed her residency in Primary Care Internal Medicine at San Francisco General Hospital (SFGH) and UCSF. She teaches in the Advanced Training in Clinical Research Program at UCSF and is an attending physician in the General Medical Clinic at SFGH. The AIDS Research Institute at UCSF recognized Dr Buchbinder's service and commitment toward advancing the scientific development and early careers of junior faculty, residents, interns and post-doctoral fellows working in the field of HIV/AIDS research and clinical care by selecting her as the recipient of the 2009 award for Outstanding Mentorship. Her research is focused on understanding risk factors for HIV transmission and acquisition, and developing and evaluating HIV prevention interventions in high-risk populations. Along with Dr Michael Robertson, she chaired the Step vaccine trial.
Dr Lawrence Corey is Head of the University of Washington's Virology Division and Co-Director of the Fred Hutchinson Cancer Research Center's Vaccine and Infectious Disease Division. He is also a Professor of Medicine and Laboratory Medicine at the University of Washington, USA. In 1999, Dr Corey was selected by the National Institutes of Health to lead the HIV Vaccine Trials Network. Research in Dr Corey's laboratories includes studies dealing with the pathogenesis, prevention and treatment of HIV and herpes virus infections. These investigations include studies of the host response to HSV infections and development of vaccines for both genital herpes and HIV. His labs have also pioneered novel tests for diagnosing and monitoring therapies for viral infections. Dr Corey is also an infectious disease attending physician at the Fred Hutchinson Cancer Research Center. He is a member of the Institute of Medicine and the Board of Scientific Counselors-Basic Sciences of the NCI, a fellow of the Infectious Diseases Society of America, and a member of the American Society for Clinical Investigation, American Epidemiological Society and Association of American Physicians. He is the recipient of the Pan American Society Clinical Virology Award, the American Society for STD Research Parran Award, the University of Michigan Medical School Distinguished Alumnus Award and the Infectious Diseases Society of America Ender's Award. Dr Corey received his MD from the University of Michigan. He received his infectious diseases training at the University of Washington. He has authored over 600 scientific publications, and has also reviewed numerous scientific journals and proceedings as an editorial board member.
Dr James Kublin is currently Director of the HIV Vaccine Trials Network based at Fred Hutchinson Cancer Research Center, and a faculty member in the Department of Global Health at the University of Washington, USA. Dr Kublin is also the founder and Director of the Center for Collaborative Research, which supports collaborative global health research endeavors by providing scientific and biomedical research expertise, project management services, and collaborative technology solutions. The Gates Foundation recently awarded Dr Kublin a Grand Challenges Exploration award to apply high-throughput system analyses to malaria vaccine development. Jim completed his BS and MD at Georgetown University, where he also conducted research on malaria. He received an MPH and completed a residency in Preventive Medicine at Johns Hopkins University. Jim continued work in vaccine development and the molecular epidemiology of drug resistance to malaria while attending the University of Maryland's School of Medicine for his fellowship in Vaccinology at the Center for Vaccine Development.